Large Cap Stocks At 52-Week Highs: Friday’s Full List
A short list of new market highs shows a wide divergence in valuation and growth.
Strength was not concentrated on Friday. The 52-week-high list for Large Caps is a spare collection of solo acts from different industries, with just 4 names making the screen. The largest is Anheuser-Busch InBev SA/NV (BUD), with a market value of about $171.1 billion. With the S&P 500 returning just +0.2% over the last month, the central question is what kind of business quality underpins these individual breakouts.
Here are the names at their strongest price of the past year.
Every Name On The List
- Where The Selling Ran Deepest: 3 S&P 500 Stocks At 52-Week Lows
- 31 Stocks Hit 52-Week Lows On Friday
- 4 S&P 500 Stocks Hit 52-Week Highs On Friday
- 30 Small Cap Stocks Hit 52-Week Highs On Friday
- Mid Cap Stocks At 52-Week Highs: Friday’s Full List
- S&P 500 Movers | Winners: AMZN, DXCM, MPWR | Losers: GDDY, CTVA, COIN
Here are all 4 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| BUD | $171.1 Bil | 0.4% | 5.9% | 7.8% | 32.3% |
| BMY | $133.1 Bil | 0.7% | 5.2% | 17.0% | 48.9% |
| EOG | $79.1 Bil | 2.2% | 1.6% | 16.5% | 26.9% |
| EA | $52.5 Bil | 0.1% | 0.4% | 2.1% | 34.8% |
Has one stock’s valuation outrun its fundamentals?
Electronic Arts (EA) stands out for its price relative to its earnings. The company trades at 59.1 times trailing earnings, the highest multiple on the list. That valuation is paired with revenue growth of 0.9% over the last twelve months and an operating margin of 15.4%. For contrast, Bristol-Myers Squibb (BMY) had the strongest one-month run, up 17.0%, yet it trades at 14.4 times trailing earnings with revenue growth of 3.1% and an operating margin of 28.1%.
A new high is the start of the work, not the end.
A list of stocks at their strongest price of the year is a useful screen for what is working. Strength often persists. But a high price is a data point, not a verdict on a company’s future. The disciplined move for an investor is to treat the new high as a prompt to investigate. The essential work is determining whether the business itself is strong enough to earn its new valuation.
A new high tells you what the market already believes. The harder question is which of these runs management itself is underwriting. Our Guidance Momentum screen tracks exactly that: stocks where the company raised its own forward numbers.
New Highs Grow Positions Faster Than Plans Do
A new high is real progress, and it is also how winners grow into outsized positions. How much damage any single position could do to your net worth is a question with a precise answer. The Trefis Wealth team computes it for investors professionally, with the same rules-based systematic discipline that runs our High Quality Portfolio. Request a free vulnerability audit of your biggest positions.